Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. Ovarian cancer specifically refers to cancer that forms in the cells of the Ovaries. To understand Ovarian cancer better, let’s first understand the basic structure of the Ovary.
How Ovary is structured?
The cervix is the lower part of the uterus (womb) that connects the uterus to the vagina. It has a cylindrical shape and is composed of several layers of tissue.
The cervix plays several important roles in the female reproductive system, including providing structural support to the uterus, producing mucus to facilitate sperm transport, and serving as a barrier to protect the uterus from infections.
Additionally, the cervix undergoes changes throughout the menstrual cycle and pregnancy, influenced by hormones such as estrogen and progesterone.
A Cervix is made up of:
- External OS: This is the opening of the cervix that leads from the cervical canal into the vagina. During childbirth, the cervix dilates (widens) to allow the passage of the baby through the birth canal.
- Cervical Canal: This is the passageway that runs through the center of the cervix. It connects the uterine cavity (the space inside the uterus) to the vaginal canal. The cervical canal is lined with glandular cells that produce mucus, which helps protect the uterus from infections and facilitates the passage of sperm.
- Endocervix: This is the inner lining of the cervical canal. It consists of columnar epithelial cells that produce mucus.
- Ectocervix: Also known as the exocervix or portio, this is the outer surface of the cervix that is visible during a pelvic examination. The ectocervix is covered by squamous epithelial cells, which are similar to the cells lining the vagina.
- Transformation Zone: This is the area of the cervix where the endocervical canal meets the ectocervix. It is the most common site for cervical cell changes (such as those seen in cervical dysplasia or cervical cancer) because it is a transitional area where different types of cells meet.
What is Cervical Cancer?
Cervical cancer specifically refers to cancer that forms in the cells of the Cervix. Cervical cancer usually develops slowly over time. Before cancer appears in the cervix, the cells of the cervix go through changes known as dysplasia, in which abnormal cells begin to appear in the cervical tissue.
Over time, if not destroyed or removed, the abnormal cells may become cancer cells and start to grow and spread more deeply into the cervix and to surrounding areas.
What are the different types of Cervical Cancer?
Cervical cancer is primarily classified based on the type of cells from which it originates.
The two main types of cervical cancer are:
- Squamous cell carcinoma: This type of cervical cancer originates in the squamous epithelial cells that line the outer surface of the cervix (ectocervix). Squamous cell carcinoma accounts for the majority of cervical cancer cases, approximately 70% to 80%.
- Adenocarcinoma: Adenocarcinoma develops from the glandular cells that line the cervical canal (endocervix). It accounts for about 20% to 30% of cervical cancer cases.
Apart from these main types, there are several subtypes of cervical cancer, which are primarily determined by the presence of specific genetic mutations or the presence of the human papillomavirus (HPV), which is a known risk factor for cervical cancer. Some common subtypes include:
- Adenosquamous carcinoma: This subtype contains both squamous and glandular cancer cells and is less common than pure squamous or adenocarcinoma.
- Small cell carcinoma: This rare subtype of cervical cancer originates from small, round cells and tends to be more aggressive than other types.
- Clear cell carcinoma: Clear cell carcinoma is another rare subtype of cervical cancer characterized by clear cytoplasm in cancer cells.
- Neuroendocrine tumors: These are rare tumors that arise from neuroendocrine cells in the cervix and can include various subtypes, such as carcinoid tumors and neuroendocrine carcinoma.
It’s important to note that cervical cancer subtypes may have different prognoses and responses to treatment, so accurate diagnosis and classification are crucial for determining the most appropriate treatment approach. Additionally, screening tests such as Pap smears and HPV testing can help detect cervical cancer at early stages when it’s more treatable.
How do I know if I have cervical cancer?
Cervical cancer is a significant public health concern in India, where it ranks as one of the leading causes of cancer-related deaths among women. Early detection is key to successful treatment and improved outcomes. Understanding the signs and symptoms of cervical cancer is crucial for timely diagnosis and intervention.
Following ae common signs and symptoms of cervical cancer. Recognizing these potential warning signs can help to seek medical attention promptly.
- Abnormal vaginal bleeding: This is the most common symptom of cervical cancer. It may include bleeding between periods, bleeding after sexual intercourse, bleeding after menopause, or unusually heavy or prolonged menstrual periods.
- Pelvic pain: Some women with cervical cancer may experience pelvic pain that is not related to menstruation or intercourse. This pain may be dull, achy, or cramp-like and may radiate to the lower back or thighs.
- Pain during sexual intercourse: Pain or discomfort during sexual intercourse (dyspareunia) can occur as a result of cervical cancer, especially if the tumor has grown large enough to cause pressure or obstruction.
- Vaginal discharge: Unusual vaginal discharge that may be watery, bloody, or have a foul odor can sometimes be a symptom of cervical cancer. This discharge may occur between periods or after menopause.
- Changes in urinary or bowel habits: Advanced cervical cancer can sometimes cause urinary symptoms such as urinary frequency, urgency, or difficulty urinating, as well as bowel symptoms such as constipation or blood in the stool.
It’s important to note that many of these symptoms can also be caused by conditions other than cervical cancer, such as infections or benign (non-cancerous) growths. However, if you experience any of these symptoms, especially if they persist for more than a few weeks, it’s essential to see a doctor for evaluation and further testing.
Screening tests such as Pap smears and HPV testing are also important for early detection of cervical cancer, even in the absence of symptoms. Regular cervical cancer screening can help detect precancerous changes or early-stage cancer when it’s most treatable.
HPV vaccination is also a critical tool in preventing cervical cancer and other HPV-related diseases.
What factors contribute to the development of cervical cancer?
Several factors contribute to the development of cervical cancer are:
- Human Papillomavirus (HPV) infection: HPV is the primary risk factor for cervical cancer. Persistent infection with high-risk strains of HPV, particularly HPV types 16 and 18, can lead to the development of cervical cancer over time. HPV is a sexually transmitted infection, and factors such as early age at first sexual intercourse, multiple sexual partners, and lack of condom use increase the risk of HPV transmission.
- Cigarette smoking: Smoking tobacco increases the risk of cervical cancer and can accelerate the progression of precancerous cervical lesions to invasive cancer. Chemicals found in tobacco smoke can damage cervical cells and weaken the immune system’s ability to fight HPV infection.
- Weak immune system: A weakened immune system, whether due to conditions such as HIV/AIDS or immunosuppressive medications, can increase the risk of HPV persistence and progression to cervical cancer.
- Multiple sexual partners: Having multiple sexual partners or engaging in sexual activity at an early age increases the likelihood of HPV exposure and infection, which can elevate the risk of cervical cancer.
- Long-term use of oral contraceptives: Some studies suggest that long-term use of hormonal contraceptives, particularly oral contraceptives, may be associated with a slightly increased risk of cervical cancer, although the underlying mechanisms are not fully understood.
- Genetic factors: Certain genetic factors may predispose individuals to cervical cancer, although the role of genetics in cervical cancer development is not yet fully understood.
It’s important to note that having one or more risk factors does not necessarily mean that a person will develop cervical cancer. Conversely, some individuals with no known risk factors may still develop the disease. Additionally, many cases of cervical cancer occur in individuals with no family history of the disease. Regular screenings, early detection, and lifestyle modifications can help reduce the risk of cervical cancer.
How is cervical cancer diagnosed?
Cervical cancer is diagnosed through a combination of screening tests, clinical evaluation, and diagnostic procedures.
- Screening Tests:
- Pap Smear (Pap Test): A Pap smear is a routine screening test used to detect abnormal cervical cells before they become cancerous. During a Pap smear, cells are collected from the cervix and examined under a microscope for any abnormalities.
- HPV Testing: HPV testing is often performed in conjunction with a Pap smear to detect the presence of high-risk strains of the human papillomavirus (HPV), which is the primary risk factor for cervical cancer. HPV testing can help identify women at higher risk of developing cervical cancer.
- Clinical Evaluation:
- Physical Examination: A healthcare provider may perform a pelvic examination to assess the cervix for any abnormalities, such as visible lesions or growths.
- Medical History: Gathering information about the patient’s medical history, including any symptoms they may be experiencing, previous Pap smear results, HPV vaccination status, sexual history, and family history of cancer.
- Diagnostic Procedures:
- Colposcopy: If abnormalities are detected during a Pap smear or HPV test, a colposcopy may be performed. During a colposcopy, a special instrument called a colposcope is used to examine the cervix more closely. If suspicious areas are identified, a biopsy may be taken for further evaluation.
- Biopsy: A biopsy involves the removal of a small sample of tissue from the cervix for examination under a microscope by a pathologist. A biopsy is the definitive diagnostic test for cervical cancer and can confirm the presence of cancerous cells.
- Imaging Studies: In cases where cervical cancer is suspected or diagnosed, imaging studies such as ultrasound, MRI (magnetic resonance imaging), or CT (computed tomography) or PET CT scans may be performed to determine the extent of the disease (staging) and help guide treatment decisions.
Once a diagnosis of cervical cancer is confirmed, further tests may be performed to determine the stage of the cancer and plan appropriate treatment.
Early detection and prompt treatment are key to improving outcomes for women diagnosed with cervical cancer. Regular cervical cancer screening and vaccination against HPV are essential for preventing the development of cervical cancer or detecting it at an early, more treatable stage.
What are the stages of cervical cancer?
Cervical cancer staging is a system used to describe the extent of the cancer and guide treatment decisions. The stages of cervical cancer are typically classified using the FIGO (International Federation of Gynecology and Obstetrics) staging system, which takes into account the size of the tumor, its spread to nearby tissues or lymph nodes, and whether it has metastasized (spread) to distant organs.
The stages of cervical cancer are as follows:
- Stage I: At this stage, the cancer is confined to the cervix and has not spread to nearby tissues or organs. Stage I is further divided into:
- Stage IA: The cancer is microscopic and is only visible under a microscope.
- Stage IB: The cancer is visible to the naked eye and may involve a larger area of the cervix.
- Stage II: The cancer has spread beyond the cervix to nearby tissues, but it has not yet reached the walls of the pelvis or the lower part of the vagina. Stage II is further divided into:
- Stage IIA: The cancer has spread to the upper part of the vagina but not to the walls of the pelvis.
- Stage IIB: The cancer has spread to the walls of the pelvis but not to nearby organs.
- Stage III: The cancer has spread to the lower part of the vagina or the walls of the pelvis, and it may be blocking the ureters (tubes that carry urine from the kidneys to the bladder). Stage III is further divided into:
- Stage IIIA: The cancer has spread to the lower part of the vagina but not to the walls of the pelvis.
- Stage IIIB: The cancer has spread to the walls of the pelvis or is blocking the ureters.
- Stage IV: The cancer has spread beyond the pelvis to other parts of the body, such as the bladder, rectum, or distant organs. Stage IV is further divided into:
- Stage IVA: The cancer has spread to nearby organs, such as the bladder or rectum.
- Stage IVB: The cancer has spread to distant organs, such as the lungs, liver, or bones.
The stage of cervical cancer is determined based on imaging tests, physical examination, biopsy results, and other diagnostic procedures.
Staging helps oncologists plan appropriate treatment strategies and predict the prognosis (outcome) for patients with cervical cancer.
How is cervical cancer treated?
Cervical cancer treatment depends on several factors, including the stage of the cancer, the patient’s overall health, and their preferences. Treatment for cervical cancer may involve one or more of the following approaches:
- Surgery:
- Conization (Cone Biopsy): In early-stage cervical cancer (Stage 0 or IA), a cone biopsy may be performed to remove a cone-shaped piece of tissue from the cervix containing the cancerous cells.
- Hysterectomy: In more advanced stages of cervical cancer, a hysterectomy may be recommended to remove the uterus and cervix, and sometimes nearby tissues and lymph nodes, depending on the extent of the cancer.
- Pelvic Exenteration: For advanced cervical cancer that has spread to nearby organs, such as the bladder or rectum, pelvic exenteration may be performed to remove these organs along with the cervix and other affected tissues.
- Chemotherapy:
- Systemic Chemotherapy: Chemotherapy drugs may be administered orally or intravenously to kill cancer cells throughout the body. Chemotherapy is often used in combination with radiation therapy (chemoradiation) to enhance treatment effectiveness.
- Targeted Therapy: Targeted therapy drugs may be used to specifically target cancer cells with certain genetic mutations or characteristics, such as the presence of the HPV.
- Immunotherapy: Immunotherapy drugs may be used to boost the body’s immune response against cervical cancer cells by blocking immune checkpoint proteins that inhibit immune system activity.
- Radiation Therapy:
In the treatment of cervical cancer, various advanced radiation therapy techniques may be utilized to precisely target the tumor while minimizing radiation exposure to surrounding healthy tissues. Two such techniques are IMRT and IGRT.- Intensity-Modulated Radiation Therapy (IMRT):
- IMRT is a highly sophisticated form of external beam radiation therapy (EBRT) that delivers precise, highly focused radiation beams to the tumor while sparing nearby healthy tissues.
- In IMRT, the intensity of the radiation beams is modulated to conform to the shape and size of the tumor, allowing for higher radiation doses to be delivered to the tumor while minimizing radiation exposure to adjacent critical structures.
- This technique utilizes advanced computer algorithms to optimize the delivery of radiation beams from multiple angles, allowing for precise targeting of the tumor while minimizing side effects.
- IMRT is particularly useful in the treatment of cervical cancer, where the tumor may be located close to critical structures such as the bladder, rectum, and intestines.
- Image-Guided Radiation Therapy (IGRT):
- IGRT is a radiation therapy technique that uses real-time imaging technology to precisely target the tumor before and during treatment.
- Prior to each radiation treatment session, imaging scans such as X-rays, CT scans, or cone-beam CT scans are used to visualize the tumor and surrounding anatomy.
- By comparing these images to the treatment plan, adjustments can be made to ensure that the radiation beams are accurately aligned with the tumor, even if there are slight variations in position or shape from day to day.
- IGRT helps to minimize the risk of radiation exposure to nearby healthy tissues and organs while maximizing the dose delivered to the tumor, thereby improving treatment outcomes and reducing side effects.
- This technique is particularly beneficial in cervical cancer treatment, where the position of the tumor and nearby critical structures may vary during the course of treatment due to factors such as bladder and bowel filling.
- Brachytherapy: Brachytherapy involves the placement of radioactive sources directly into or near the cervix to deliver targeted radiation to the tumor while minimizing damage to surrounding healthy tissues.
- Intensity-Modulated Radiation Therapy (IMRT):
- Palliative Care:
- Palliative care focuses on relieving symptoms and improving quality of life for patients with advanced cervical cancer that cannot be cured.
- Palliative treatments may include pain management, symptom control, and supportive care services.
The choice of treatment for cervical cancer is individualized based on the specific characteristics of the cancer and the patient’s preferences.
Multidisciplinary teams of healthcare providers, including gynecologic oncologists, radiation oncologists, medical oncologists, and other specialists, collaborate to develop personalized treatment plans that optimize outcomes for patients with cervical cancer.
Early detection, timely treatment, and ongoing surveillance are key to improving survival and quality of life for individuals affected by cervical cancer.
The incidence of Cervical cancer in India has been steadily rising over the past few decades.
Statistics of Cervix Uteri Cancer in India in year 2022 at a glance:
Top 5 Most Frequent Cancers In India (Year 2022):
